1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Prosight Management, LP Buys Kura Oncology Inc, uniQure NV, Homology Medicines Inc, Sells Cigna Corp, WellCare Health Plans Inc, Hanger Inc

Investment company Prosight Management, LP (Current Portfolio) buys Kura Oncology Inc, uniQure NV, Homology Medicines Inc, Bristol-Myers Squibb Company, Strongbridge Biopharma PLC, sells Cigna Corp, WellCare Health Plans Inc, Hanger Inc, Nevro Corp, ASGN Inc during the 3-months ended 2019Q2, according to the most recent filings of the investment company, Prosight Management, LP. As of 2019Q2, Prosight Management, LP owns 38 stocks with a total value of $197 million. These are the details of the buys and sells.

For the details of Prosight Management, LP's stock buys and sells, go to https://www.gurufocus.com/guru/prosight+management%2C+lp/current-portfolio/portfolio

These are the top 5 holdings of Prosight Management, LP
  1. Zimmer Biomet Holdings Inc (ZBH) - 164,619 shares, 9.86% of the total portfolio. Shares added by 33.29%
  2. Bristol-Myers Squibb Company (BMY) - 410,490 shares, 9.47% of the total portfolio. Shares added by 45.05%
  3. Kura Oncology Inc (KURA) - 867,810 shares, 8.69% of the total portfolio. Shares added by 401.93%
  4. Reata Pharmaceuticals Inc (RETA) - 124,965 shares, 5.99% of the total portfolio. Shares reduced by 28.88%
  5. Iovance Biotherapeutics Inc (IOVA) - 400,000 shares, 4.99% of the total portfolio. Shares reduced by 56.38%
New Purchase: uniQure NV (QURE)

Prosight Management, LP initiated holding in uniQure NV. The purchase prices were between $52.76 and $82.19, with an estimated average price of $63.55. The stock is now traded at around $56.90. The impact to a portfolio due to this purchase was 4.77%. The holding were 120,000 shares as of .

New Purchase: Homology Medicines Inc (FIXX)

Prosight Management, LP initiated holding in Homology Medicines Inc. The purchase prices were between $18.35 and $30.34, with an estimated average price of $21.81. The stock is now traded at around $16.78. The impact to a portfolio due to this purchase was 3.67%. The holding were 369,048 shares as of .

New Purchase: Evolus Inc (EOLS)

Prosight Management, LP initiated holding in Evolus Inc. The purchase prices were between $13.19 and $28.36, with an estimated average price of $19.84. The stock is now traded at around $14.05. The impact to a portfolio due to this purchase was 0.84%. The holding were 112,590 shares as of .

New Purchase: Personalis Inc (PSNL)

Prosight Management, LP initiated holding in Personalis Inc. The purchase prices were between $27 and $30.25, with an estimated average price of $28.28. The stock is now traded at around $18.05. The impact to a portfolio due to this purchase was 0.78%. The holding were 56,446 shares as of .

New Purchase: Arqule Inc (ARQL)

Prosight Management, LP initiated holding in Arqule Inc. The purchase prices were between $4.77 and $11.01, with an estimated average price of $6.96. The stock is now traded at around $8.96. The impact to a portfolio due to this purchase was 0.47%. The holding were 83,675 shares as of .

New Purchase: ADMA Biologics Inc (ADMA)

Prosight Management, LP initiated holding in ADMA Biologics Inc. The purchase prices were between $3.52 and $5.24, with an estimated average price of $4.42. The stock is now traded at around $3.95. The impact to a portfolio due to this purchase was 0.37%. The holding were 185,721 shares as of .

Added: Kura Oncology Inc (KURA)

Prosight Management, LP added to a holding in Kura Oncology Inc by 401.93%. The purchase prices were between $14.71 and $19.79, with an estimated average price of $16.58. The stock is now traded at around $17.83. The impact to a portfolio due to this purchase was 6.96%. The holding were 867,810 shares as of .

Added: Bristol-Myers Squibb Company (BMY)

Prosight Management, LP added to a holding in Bristol-Myers Squibb Company by 45.05%. The purchase prices were between $44.62 and $49.34, with an estimated average price of $46.57. The stock is now traded at around $46.98. The impact to a portfolio due to this purchase was 2.94%. The holding were 410,490 shares as of .

Added: Strongbridge Biopharma PLC (SBBP)

Prosight Management, LP added to a holding in Strongbridge Biopharma PLC by 172.73%. The purchase prices were between $2.82 and $4.96, with an estimated average price of $3.67. The stock is now traded at around $2.53. The impact to a portfolio due to this purchase was 2.57%. The holding were 2,546,997 shares as of .

Added: Zimmer Biomet Holdings Inc (ZBH)

Prosight Management, LP added to a holding in Zimmer Biomet Holdings Inc by 33.29%. The purchase prices were between $112.14 and $128.84, with an estimated average price of $120.53. The stock is now traded at around $137.01. The impact to a portfolio due to this purchase was 2.46%. The holding were 164,619 shares as of .

Added: UroGen Pharma Ltd (URGN)

Prosight Management, LP added to a holding in UroGen Pharma Ltd by 65.29%. The purchase prices were between $32.75 and $40.35, with an estimated average price of $36.86. The stock is now traded at around $32.01. The impact to a portfolio due to this purchase was 1.88%. The holding were 260,928 shares as of .

Added: Clovis Oncology Inc (CLVS)

Prosight Management, LP added to a holding in Clovis Oncology Inc by 80.44%. The purchase prices were between $12.81 and $25.67, with an estimated average price of $18.09. The stock is now traded at around $5.60. The impact to a portfolio due to this purchase was 1.52%. The holding were 450,000 shares as of .

Sold Out: WageWorks Inc (WAGE)

Prosight Management, LP sold out a holding in WageWorks Inc. The sale prices were between $38.05 and $52.76, with an estimated average price of $47.21.

Sold Out: Macrogenics Inc (MGNX)

Prosight Management, LP sold out a holding in Macrogenics Inc. The sale prices were between $14.51 and $19.71, with an estimated average price of $17.19.

Sold Out: MeiraGTx Holdings PLC (MGTX)

Prosight Management, LP sold out a holding in MeiraGTx Holdings PLC. The sale prices were between $17.38 and $26.88, with an estimated average price of $20.67.

Sold Out: Cerecor Inc (CERC)

Prosight Management, LP sold out a holding in Cerecor Inc. The sale prices were between $4.49 and $6.22, with an estimated average price of $5.26.

Sold Out: Enanta Pharmaceuticals Inc (ENTA)

Prosight Management, LP sold out a holding in Enanta Pharmaceuticals Inc. The sale prices were between $81.3 and $97.35, with an estimated average price of $89.96.



Here is the complete portfolio of Prosight Management, LP. Also check out:

1. Prosight Management, LP's Undervalued Stocks
2. Prosight Management, LP's Top Growth Companies, and
3. Prosight Management, LP's High Yield stocks
4. Stocks that Prosight Management, LP keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK